yongwen he

Dr. yongwen he


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 January 2024 in Cell Research
Verified
Journal Article
Open access
PDF file
YYYating Yi
Yating Yi
YLYouqi Li
Youqi Li
SZShiwen Zhang
Shiwen Zhang
YMYi Men
Yi Men
YWYuhong Wang
Yuhong Wang
HZHu Zhao
Hu Zhao
Achieving uniform optical resolution for a large tissue sample is a major challenge for deep imaging. For conventional tissue clearing methods, loss of resolution and quality in deep regions is inevitable due to limited transparency. Here we describe the Transparent Embedding Solvent System (TESOS) method, which combines tissue clearing, transparent embedding, sectioning and block-face imaging. We used TESOS to acquire volumetric images of uniform resolution for an adult mouse whole-body sample. The TESOS method is highly versatile and can be combined with different microscopy systems to achieve uniformly high resolution. With a light sheet microscope, we imaged the whole body of an adult mouse, including skin, at a uniform 0.8 × 0.8 × 3.5 μm3 voxel resolution within 120 h. With a confocal microscope and a 40×/1.3 numerical aperture objective, we achieved a uniform sub-micron resolution in the whole sample to reveal a complete projection of individual nerve axons within the central or peripheral nervous system. Furthermore, TESOS allowed the first mesoscale connectome mapping of individual sensory neuron axons spanning 5 cm from adult mouse digits to the spinal cord at a uniform sub-micron resolution.

19 May 2021 in Oncology Letters
Verified
Journal Article
Open access
PDF file
XRXiaobin Ren
Xiaobin Ren
LLLei Li
Lei Li
JWJianhua Wu
Jianhua Wu
KLKen Lin
Ken Lin
YHyongwen he
yongwen he
LBLi Bian
Li Bian
The most abundant cells in the tumor microenvironment are cancer‑associated fibroblasts (CAFs). They play an important role in oral squamous cell carcinoma (OSCC) angiogenesis, invasion and metastasis. Platelet‑derived growth factor (PDGF)‑BB has an obvious regulating effect on the formation of CAFs through binding to PDGF receptor (PDGFR)‑β, but the role of long non‑coding (lnc)RNA in PDGF‑BB‑induced transformation of fibroblasts into CAFs remains poorly understood. Using an lncRNA ChIP, 370 lncRNA transcripts were identified to be significantly and differentially expressed between fibroblasts and PDGF‑BB‑induced fibroblasts, including 240 upregulated lncRNAs and 130 downregulated lncRNAs, indicating that lncRNAs are involved in the regulation of the transformation of CAFs. Previous studies have shown that the nuclear factor (NF)‑κB signaling pathway plays an important role in the activation of CAFs. Dual‑luciferase reporter assay and co‑immunoprecipitation were conducted to confirm that the leucine‑rich adaptor protein 1‑like (LURAP1L), which is the target of lncRNA LURAP1L antisense RNA 1 (LURAP1L‑AS1) had a positive regulatory effect on I‑κB kinase (IKK)/NF‑κB signaling. Therefore, LURAP1L‑AS1 was selected and PDGF‑BB was demonstrated to upregulate the expression of LURAP1L‑AS1 and LURAP1L, which was reversed by a PDGFR‑β inhibitor. Subsequently, knocking down LURAP1L‑AS1 suppressed the expression of PDGF‑BB‑induced fibroblast activation marker protein α‑smooth muscle actin, fibroblast activation protein‑α, PDGFR‑β and phosphorylated (p)‑PDGFR‑β. IKKα, p‑IĸB and p‑NF‑κB were downregulated by the knockdown of LURAP1L‑AS1 and upregulated by overexpression of LURAP1L‑AS1. The present study indicates that LURAP1L‑AS1/LURAP1L/IKK/IĸB/NF‑κB plays an important regulatory role in PDGF‑BB‑induced fibroblast activation and may become a potential target for the treatment of OSCC.

20 December 2017 in Oncology Reports
Verified
Journal Article
Closed access
PDF file
ZLZiliang Li
Ziliang Li
JLJianqi Liu
Jianqi Liu
LLLei Li
Lei Li
SSShuai Shao
Shuai Shao
JWJianhua Wu
Jianhua Wu
YHyongwen he
yongwen he
The present study aimed to assess the induction of epithelial-mesenchymal transition (EMT), invasion, and metastasis by the chemokine CXCL9/receptor CXCR3 axis in tongue squamous cell carcinoma (TSCC), unveiling the underlying mechanisms and providing new insights into the prevention and treatment of oral cancer metastasis. The expression levels of CXCL9 and CXCR3 in TSCC tissue specimens were determined by immunohistochemistry, assessing differences between samples with cervical lymph node metastasis and those without. Moreover, protein expression or activity in the TSCC Cal-27 cell line was controlled by neutralizing antibodies, gene transfection, or knock-out. Then, alterations of cell proliferation, migration, invasion, and the cytoskeleton were analyzed by CCK-8, cell scratch, Transwell, and cyto-skeleton staining assays, respectively. Alterations of EMT markers (E-cadherin and vimentin) in Cal-27 cells were detected by immunofluorescence and western blotting. In addition, western blotting was utilized to detect protein expression levels of Akt2, p-Akt2, eIF4E and p-eIF4E, and to explore the regulatory roles and mechanisms of the CXCL9/CXCR3 axis in invasion and metastasis. Significantly increased expression levels of CXCL9 and CXCR3 were detected in tissue specimens with lymph node metastasis compared with those without (P<0.01). Overexpression of CXCL9/CXCR3 in Cal-27 cells resulted in cytoskeleton alterations, decreased E-cadherin expression, increased vimentin levels, enhanced migration and invasion (P<0.05), and increased phosphorylated Akt2 and eIF4E levels (P<0.05). These results revealed that in TSCC, the CXCL9/CXCR3 axis could activate the Akt signaling pathway, with EMT and cytoskeleton rearrangement, promoting invasion and metastasis.

14 April 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
LLLei Li
Lei Li
XWXiao-Li Wang
Xiao-Li Wang
QLQian Lei
Qian Lei
CSChuan-Zheng Sun
Chuan-Zheng Sun
YXYan Xi
Yan Xi
YHyongwen he
yongwen he
Head and neck cancer is the sixth most common malignancy around the world, and 90% of cases are squamous cell carcinomas. In this study, we performed a systematic investigation of the immunogenomic landscape to identify prognostic biomarkers for head and neck squamous cell carcinoma (HNSCC). We analyzed the expression profiles of immune‐related genes (IRGs) and clinical characteristics by interrogating RNA-seq data from 527 HNSCC patients in the cancer genome atlas (TCGA) dataset, including 41 HPV+ and 486 HPV− samples. We found that differentially expressed immune genes were closely associated with patient prognosis in HNSCC by comparing the differences in gene expression between cancer and normal samples and performing survival analysis. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses were performed to annotate the biological functions of the differentially expressed immunogenomic prognosis-related genes. Two additional cohorts from the Oncomine database were used for validation. 65, 56 differentially expressed IRGs was associated with clinical prognosis in total and HPV- samples, respectively. Furthermore, we extracted 10, 11 prognosis-related IRGs from 65, 56 differentially expressed IRGs, respectively. They were significantly correlated with clinical prognosis and used to construct the prognosis prediction models. The multivariable ROC curves (specifically, the AUC) were used to measure the accuracy of the prognostic models. These genes were mainly enriched in several gene ontology (GO) terms related to immunocyte migration and receptor and ligand activity. KEGG pathway analysis revealed enrichment of pathways related to cytokine−cytokine receptor interactions, which are primarily involved in biological processes. In addition, we identified 63 differentially expressed transcription factors (TFs) from 4784 differentially expressed genes, and 16 edges involving 18 nodes were formed in the regulatory network between differentially expressed TFs and the high-risk survival-associated IRGs. B cell and CD4 T cell infiltration levels were significantly negatively correlated with the expression of prognosis-related immune genes regardless of HPV status. In conclusion, this comprehensive analysis identified the prognostic IRGs as potential biomarkers, and the model generated in this study may enable an accurate prediction of survival.

11 January 2024 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
JSJingpei Shi
Jingpei Shi
XYXiaonan Yu
Xiaonan Yu
GLGuoyu Li
Guoyu Li
XZXiaoyu Zhao
Xiaoyu Zhao
JCJiwen Chen
Jiwen Chen
YHyongwen he
yongwen he

26 June 2023 in BMC Cancer
Verified
Journal Article
Open access
PDF file
WWWei-Zhou Wang
Wei-Zhou Wang
XCXue Cao
Xue Cao
LBLi Bian
Li Bian
YGYue Gao
Yue Gao
MYMing Yu
Ming Yu
YHyongwen he
yongwen he
Background: Cancer-associated fibroblasts (CAFs) have significant tumor regulatory functions, and CAFs-derived exosomes (CAFs-Exo) released from CAFs play an important role in the progression of oral squamous cell carcinoma (OSCC). However, a lack of comprehensive molecular biological analysis leaves the regulatory mechanisms of CAFs-Exo in OSCC unclear. Methods: We used platelet derived growth factor-BB (PDGF-BB) to induce the transformation of human oral mucosa fibroblast (hOMF) into CAFs, and extracted exosomes from the supernatant of CAFs and hOMF. We validated the effect of CAFs-Exo on tumor progression by exosomes co-culture with Cal-27 and tumor-forming in nude mice. The cellular and exosomal transcriptomes were sequenced, and immune regulatory genes were screened and validated using mRNA-miRNA interaction network analysis in combination with publicly available databases. Results: The results showed that CAFs-Exo had a stronger ability to promote OSCC proliferation and was associated with immunosuppression. We discovered that the presence of immune-related genes in CAFs-Exo may regulate the expression of PIGR, CD81, UACA, and PTTG1IP in Cal-27 by analyzing CAFs-Exo sequencing data and publicly available TCGA data. This may account for the ability of CAFs-Exo to exert immunomodulation and promote OSCC proliferation. Conclusions: CAFs-Exo was found to be involved in tumor immune regulation through hsa-miR-139-5p, ACTR2 and EIF6, while PIGR, CD81, UACA and PTTG1IP may be potentially effective targets for the treatment of OSCC in the future.